Breaking News on Supplements & Nutrition - EuropeUS edition

Headlines > Industry

News in brief

Natreon and pharma firm team up for diabetes project

13-Nov-2009

Related topics: Industry

Supplement ingredient supplier Natreon said it has teamed up with the European pharmaceutical specialty company CM&D Pharma to form Puredel with the aim of delivering Ossulin, a new oral insulin product.

New Jersey-based Natreon said it has developed the dietary platform for the product.

At a presentation at the 9th Annual Diabetes Technology Meeting in San Francisco this week the companies highlighted the product’s effect in rabbits, which they said is a well-established model for studying the oral absorption of compounds.

Dr Marco Prosdocimi, Chief Scientific Officer for Puredel and lead author of the study commented:

“The data to be presented clearly show that Ossulin delivers insulin efficiently, resulting in blood levels higher than those observed with other oral insulin products.”

Natreon's said its R&D staff in the US and India are working closely with Puredel to help facilitate the next stage of scientific validation prior to commercial development.

More news articles on this topic

Key Industry Events

Supplier Webinars